Humasys Co., Ltd. (205470) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Humasys Co., Ltd. (205470:KRX), powered by AI.

Current Price
₩2,800
P/E Ratio
-4.4
Market Cap
69.1B
Sector
Healthcare
What is the Humasys Co., Ltd. stock price forecast?

Humasys Co., Ltd. is currently trading at ₩2,800. View real-time AI analysis on Alpha Lenz.

What is Humasys Co., Ltd. insider trading activity?

View the latest insider trading data for Humasys Co., Ltd. on Alpha Lenz.

What is Humasys Co., Ltd.'s P/E ratio?

Humasys Co., Ltd.'s P/E ratio is -4.4.

Humasys Co., Ltd.

KRX · 205470
₩2,800+25(+0.90%)Market closedKRX regular session 09:00–15:30 KST
Ask about Humasys Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Humasys Co., Ltd. trades at a P/E of -4.4 (undervalued) with modest ROE of -7.0%.

Ask for details

Company Overview

Humasys Co., Ltd. is a prominent player in the biotechnology sector, specializing in the development and commercialization of in-vitro diagnostic products. The company's primary focus lies in enhancing the accuracy and efficiency of diagnostic testing, catering to a wide array of medical and healthcare needs. Humasys offers a diverse range of products, including reagent kits and diagnostic devices that are pivotal for disease detection and management. Its innovative solutions are fundamental in clinical settings, research laboratories, and various healthcare institutions. Humasys significantly contributes to the medical community by providing cutting-edge diagnostic tools that facilitate early and accurate disease detection, improving patient outcomes. The company's products are an integral part of healthcare delivery, playing a crucial role in preventive medicine and routine health screenings. As healthcare systems globally strive for improved diagnostic capabilities, Humasys stands out as a key contributor to the sector's advancements. By bridging the gap between advanced biotechnology and practical healthcare applications, Humasys Co., Ltd. holds a vital position in the financial market, reflecting the ongoing importance of reliable medical diagnostics in society.

CEO김성곤
SectorHealthcare
IndustryMedical Devices
Employees70

Company Statistics

FY 2025

Profile

₩69,090,002,800Market Cap
₩30,113,048,980Revenue
24.68MShares Out
70Employees

Margins

7.41%Gross
-33.76%EBITDA
-46.64%Operating
-70.72%Pre-Tax
-72.16%Net

Valuation

-4.42P/E
0.32P/B
2.29EV/Sales
-8.49EV/EBITDA
7.12P/FCF

Growth (CAGR)

-60.02%Rev 3Yr
-8.01%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-6.60%ROA
-7.03%ROE
-5.79%ROIC

Financial Health

₩15,717,431,770Cash & Cash Equivalents
₩75,937,781,700Net Debt
38.94%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Humasys Co., Ltd. (ticker: 205470) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 70 employees. Market cap is $69.1B.

The current price is ₩2,800 with a P/E ratio of -4.42x and P/B of 0.32x.

ROE is -7.03% and operating margin is -46.64%. Annual revenue is $30.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Humasys Co., Ltd. (205470) Stock Forecast 2026 ₩2,800 — Price, Financials & Analyst Targets | Alpha Lenz